FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| SCA Pharmaceuticals, LLC | 080545245 | Phenylephrine Hydrochloride | .04 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Phenylephrine Hydrochloride | .08 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Phenylephrine Hydrochloride | .2 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Phenylephrine Hydrochloride | .08 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Phenylephrine Hydrochloride | .16 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Potassium Chloride | 20 meq/250 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Potassium Chloride | 40 meq/500 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic | 15 mmol/250 mL; 15 mmol/250 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Rocuronium Bromide | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Rocuronium Bromide | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Rocuronium Bromide | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Rocuronium Bromide | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Sugammadex Sodium | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Sugammadex Sodium | 50 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Sugammadex Sodium | 50 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Sugammadex Sodium | 50 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Sugammadex Sodium | 100 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Trisodium Citrate Dihydrate | 40 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Vancomycin Hydrochloride | 2 g/500 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Vancomycin Hydrochloride | 1.75 g/500 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Vancomycin Hydrochloride | 1.5 g/500 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Vancomycin Hydrochloride | 1 g/250 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Vancomycin Hydrochloride | 1.5 g/250 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Diltiazem Hydrochloride | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Diltiazem Hydrochloride | 1 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Ephedrine Sulfate | 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Ephedrine Sulfate | 5 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Ephedrine Sulfate | 10 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Epinephrine | .02 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Epinephrine | .032 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Epinephrine | .016 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate | .05 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate | .02 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate | .05 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate | .02 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 037559301 | Fentanyl Citrate | .025 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 | |||
| SCA Pharmaceuticals, LLC | 080545245 | Fentanyl Citrate | .01 mg/1 mL | 2025-2 | source_no_ndc | 2026-08-12 |